• N/A
    Market Cap
  • 66.67%
    1-Year Change
  • Biotechnology
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: N/A
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$0.005
$0.005
$0.005
1-Year Range
$0.000001
$0.005
$0.005
Latest Close$0.005
Change
+$0.002 (+46.00%)
Volume4,000

Information as of 10/12/2026

Company Profile

EASTGATE ACQUISITIONS CORP
https://www.EastGateBiotech.com
N/A
Market Cap
N/A
Net Income
Sector: Healthcare
Industry: Biotechnology
65 Harbour Square, Toronto, ON, Canada, M5J 2L4
647-692-0652

Eastgate Biotech Corp., produces and distributes nutraceuticals that are based on natural therapies and absorbed naturally by the body. The company is developing pharmaceutical products, such as Lorazepam spray for acute seizures; and EGP-1214, intraoral (sublingual) insulin tablet for diabetes and metabolic syndrome. It is also developing natural healing medication and other products, including E-drops NANO, a plant essential oil for urinary and vaginal tract infections; Essential, a Vitamin D3, to improve the body's digestive, cardiovascular, and immune systems; GluCora to lower daily intake of insulin; VCleanzz, an antibacterial wash for fruits and vegetables; Cleanezze, a natural hand sanitizer; and Warts X, a natural herbal product to treats warts. The company was formerly known as Eastgate Acquisitions Corporation and changed its name to Eastgate Biotech Corp. in December 2014. Eastgate Biotech Corp. was incorporated in 1999 and is based in Toronto, Canada.

Key Executives

  • Rosella C. Perri
  • William D. Abajian
  • Joseph Schwarz

Current Ownership Distribution

  • Other2.0B (97.94%)
  • Insiders42.4M (2.06%)
  • Institutions0 (0.00%)
  • Mutual Funds0 (0.00%)